Improving Disease Management through Innovative Microbiology Solutions

DeepChek®
Genotyping through NGS & Sanger Sequencing
  • HIV
  • SARS CoV-2
  • HCV
  • TB
  • 16S RNA
More information

ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026 (EN)

https://www.businesswire.com/news/home/20260601791272/en/ABL-Diagnostics-Presents-Its-Financial-Roadmap-and-Growth-Outlook-for-2026

Read More

ABL Diagnostics Broadens UltraGene Syndromic qPCR Portfolio

https://www.einpresswire.com/article/916012021/abl-diagnostics-broadens-ultragene-syndromic-qpcr-portfolio

Read More

UltraGene Ebola: Multiplex qPCR for Outbreak Preparedness

https://www.einpresswire.com/article/915738686/ultragene-ebola-multiplex-qpcr-for-outbreak-preparedness

Read More

ABL Diagnostics Advances NGS for CMV Resistance Monitoring at SEIMC 2026

https://www.einpresswire.com/article/914346495/abl-diagnostics-advances-ngs-for-cmv-resistance-monitoring-at-seimc-2026

Read More

Subscribe to our newsletter

Scroll to Top